FI781867A - ORGANIC FOERENINGAR - Google Patents

ORGANIC FOERENINGAR

Info

Publication number
FI781867A
FI781867A FI781867A FI781867A FI781867A FI 781867 A FI781867 A FI 781867A FI 781867 A FI781867 A FI 781867A FI 781867 A FI781867 A FI 781867A FI 781867 A FI781867 A FI 781867A
Authority
FI
Finland
Prior art keywords
foereningar
organic
organic foereningar
Prior art date
Application number
FI781867A
Other languages
Finnish (fi)
Other versions
FI64938C (en
FI64938B (en
Inventor
Peter Neumann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI781867A publication Critical patent/FI781867A/en
Application granted granted Critical
Publication of FI64938B publication Critical patent/FI64938B/en
Publication of FI64938C publication Critical patent/FI64938C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI781867A 1977-06-20 1978-06-12 PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES FI64938C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH752077 1977-06-20
CH752077 1977-06-20
CH286578 1978-03-16
CH286578 1978-03-16

Publications (3)

Publication Number Publication Date
FI781867A true FI781867A (en) 1978-12-21
FI64938B FI64938B (en) 1983-10-31
FI64938C FI64938C (en) 1984-02-10

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781867A FI64938C (en) 1977-06-20 1978-06-12 PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES

Country Status (20)

Country Link
EP (1) EP0000150B1 (en)
JP (1) JPS54103876A (en)
AT (1) AT376220B (en)
AU (1) AU524000B2 (en)
CA (1) CA1105463A (en)
CY (1) CY1239A (en)
DE (1) DE2860708D1 (en)
DK (1) DK149855C (en)
ES (1) ES470917A1 (en)
FI (1) FI64938C (en)
HK (1) HK65184A (en)
IE (1) IE47212B1 (en)
IL (1) IL54948A (en)
IT (1) IT1105364B (en)
LU (1) LU88342I2 (en)
MY (1) MY8500041A (en)
NL (1) NL930126I2 (en)
NZ (1) NZ187617A (en)
PT (1) PT68191A (en)
SG (1) SG20584G (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DK525179A (en) * 1978-12-18 1980-06-19 Sandoz Ag PROCEDURE FOR PREPARING BENZOXADIAZOLES AND BENZOTHIAZOLES
BE886259A (en) * 1979-11-23 1981-05-20 Sandoz Sa NOVEL DRUGS BASED ON 1,4-DIHYDROPYRIDINE DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DEFICIENCY OR WITH SPAMOLYTIC ACTION
CH655658B (en) * 1980-09-18 1986-05-15
FI813460L (en) * 1980-11-10 1982-05-11 Sandoz Ag NYA 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-PYRIDIN DERIVATIVES DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (en) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen NEW 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICINAL PRODUCTS
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
FR2528431B1 (en) * 1982-06-15 1986-01-10 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2554109A1 (en) * 1983-11-01 1985-05-03 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPEUTICS AS MEDICAMENTS
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
JP4625637B2 (en) 2002-02-22 2011-02-02 シャイア エルエルシー Active substance delivery system and method for protecting and administering an active substance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
AT376220B (en) 1984-10-25
PT68191A (en) 1978-07-01
DK149855C (en) 1987-04-21
MY8500041A (en) 1985-12-31
AU3725278A (en) 1980-01-03
FI64938C (en) 1984-02-10
CY1239A (en) 1984-06-29
JPS6360755B2 (en) 1988-11-25
EP0000150A1 (en) 1979-01-10
JPS54103876A (en) 1979-08-15
CA1105463A (en) 1981-07-21
ATA443178A (en) 1984-03-15
ES470917A1 (en) 1979-10-01
DK149855B (en) 1986-10-13
SG20584G (en) 1985-03-08
FI64938B (en) 1983-10-31
DK262578A (en) 1978-12-21
IT7849939A0 (en) 1978-06-19
EP0000150B1 (en) 1981-05-20
DE2860708D1 (en) 1981-08-27
IL54948A (en) 1982-01-31
IT1105364B (en) 1985-10-28
IE781231L (en) 1978-12-20
HK65184A (en) 1984-08-31
IE47212B1 (en) 1984-01-25
AU524000B2 (en) 1982-08-26
IL54948A0 (en) 1978-08-31
NL930126I2 (en) 1995-02-16
LU88342I2 (en) 1994-05-04
NL930126I1 (en) 1993-11-01
NZ187617A (en) 1980-12-19

Similar Documents

Publication Publication Date Title
FI781348A (en) ORGANIC FOERENINGAR DERAS ANVAENDNING OCH FRAMSTAELLNING
FI782397A (en) BLAECKPAOFYLLNINGSSYSTEM I BLAECKINSPRUTNINGSPRINTER
FI783502A (en) HAELLBAR BLANDNING I VAETSKEFORM
FI781692A (en) HOPMONTERINGSANORDNING I SYNNERHET FOER BYGGNADSSTAELLNINGAR
FI783092A (en) MICROTURBULENGENERATOR FOER INLOPPSLAODA I PAPPERSMASKINER
FI781867A (en) ORGANIC FOERENINGAR
FI782628A (en) ORGANIC LOESNINGSMEDEL UTNYTTJANDE DELIGNIFIERINGS- OCH FOERSOCKRINGSFOERFARANDE FOER LIGNOCELLULOSAHALTIGA PLANTMATERIAL
FI782229A (en) ORGANIC FOERENINGAR DERAS FRAMSTAELLNING OCH ANVAENDNING
FI782758A (en) FOERBAETTRINGAR I MAETSYSTEM
IT1099353B (en) ORGANIC NITRILS
FI782506A (en) FOERBAETTRINGAR I GUMMIDAECKS UTBYTBARA SLITYTOR
BE863947R (en) SUBSTITUTED PHENYL-AMIDINES
FI783805A (en) ORGANIC BELAEGGNINGSKOMPOSITIONER
FI781885A (en) ORGANIC FOERENINGAR
SE7807554L (en) ORGANIC ASSOCIATIONS
FI780323A (en) PENDLINGSDAEMPARE FOER LYFTDON UPPHAENGT I EN LAENK
FI781424A (en) MAELDINLOPPSANORDNING I EN PAPPERSMASKIN
FI773440A (en) KOMPASS I SYNNERHET KUPOLKOMPASS
SE7812614L (en) TETRAPEPTIDER
FI780973A (en) FOERBAETTRINGAR I ROTERUGNAR
SE7806852L (en) ORGANIC ASSOCIATIONS
SE7807379L (en) ORGANIC FIBER
FI782734A (en) FOERBAETTRING I EN BAOGSVETSANORDNING
FI780366A (en) SOLENOIDDRIVEN I MOTSATT RIKTNING ROTERANDE AKTIVATOR
FI781947A (en) ORGANIC FOERENINGAR DERAS FRAMSTAELLNING OCH ANVAENDNING

Legal Events

Date Code Title Description
MA Patent expired
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L45

Extension date: 20030612

PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired

Owner name: NOVARTIS AG